Woodline Partners LP Horizon Therapeutics Public LTD CO Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $22 Million - $25.7 Million	-221,915 Reduced 56.5%	170,848 $19.8 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $2.7 Million - $3.15 Million	28,029 Added 7.68%	392,763 $40.4 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $7.19 Million - $7.6 Million	66,985 Added 22.5%	364,734 $39.8 Million
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $127 Million - $231 Million	-2,028,914 Reduced 87.2%	297,749 $33.9 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $123 Million - $177 Million	2,088,635 Added 877.47%	2,326,663 $144 Million
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $11.5 Million - $16.9 Million	-145,260 Reduced 37.9%	238,028 $19 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $43.2 Million - $54.9 Million	-499,815 Reduced 56.6%	383,288 $40.3 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $19.8 Million - $24.1 Million	-201,110 Reduced 18.55%	883,103 $95.2 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $367 - $441	4 Added 0.0%	1,084,213 $119 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $54.1 Million - $60.2 Million	627,338 Added 137.31%	1,084,209 $102 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $22.4 Million - $29.8 Million	312,210 Added 215.82%	456,871 $42.1 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $53 Million - $66.7 Million	-790,942 Reduced 84.54%	144,661 $10.6 Million
Q3 2020 Nov 16, 2020	SELL	$55.23 - $79.93 $26.9 Million - $38.9 Million	-486,371 Reduced 34.2%	935,603 $72.7 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $4.48 Million - $8.46 Million	148,480 Added 11.66%	1,421,974 $79 Million
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $21.1 Million - $32.6 Million	-846,662 Reduced 39.93%	1,273,494 $37.7 Million
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $53.9 Million - $77.7 Million	2,120,156 New	2,120,156 $76.8 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account